US8895064B2
(en)
|
1999-06-14 |
2014-11-25 |
Cosmo Technologies Limited |
Controlled release and taste masking oral pharmaceutical composition
|
WO2000076478A1
(en)
|
1999-06-14 |
2000-12-21 |
Cosmo S.P.A. |
Controlled release and taste masking oral pharmaceutical compositions
|
US6309663B1
(en)
*
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
AU6595900A
(en)
*
|
1999-08-18 |
2001-03-13 |
Kyowa Hakko Kogyo Co. Ltd. |
Hair growth stimulants
|
US6656504B1
(en)
*
|
1999-09-09 |
2003-12-02 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
|
US6734188B1
(en)
*
|
1999-11-01 |
2004-05-11 |
John Rhodes |
Composition for treatment of constipation and irritable bowel syndrome
|
CA2400172C
(en)
*
|
2000-02-28 |
2010-04-20 |
Genesegues, Inc. |
Nanocapsule encapsulation system and method
|
ES2303527T3
(es)
|
2000-05-10 |
2008-08-16 |
Jagotec Ag |
Procedimiento de molienda.
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
KR100508695B1
(ko)
*
|
2001-02-13 |
2005-08-17 |
한국과학기술연구원 |
인슐린의 경구투여용 제형과 그의 제조방법
|
AU2002327179A1
(en)
*
|
2001-06-07 |
2002-12-16 |
University Of Kentucky Research Foundation |
Nanoscintillation systems for aqueous-based liquid scintillation counting
|
KR100593861B1
(ko)
*
|
2001-09-24 |
2006-06-30 |
한국과학기술원 |
칼시토닌을 함유한 경구투여용 나노입자의 제조방법
|
IL160570A0
(en)
*
|
2001-09-26 |
2004-07-25 |
Baxter Int |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
|
US20060003012A9
(en)
*
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
US9308220B2
(en)
|
2001-12-11 |
2016-04-12 |
Cosmo Technologies Limited |
Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
|
ITMI20012599A1
(it)
|
2001-12-11 |
2003-06-11 |
Cosmo Spa |
Composizioni farmaceutiche per la somministrazione orale di eparina osuoi derivati, utili per la terapia di malattie infiammatorie dell'int
|
RO123110B1
(ro)
*
|
2001-12-14 |
2010-11-30 |
Jagotec Ag |
Formulare farmaceutică cu ciclosporină şi utilizarea acesteia
|
SE0104421D0
(sv)
|
2001-12-21 |
2001-12-21 |
Ponsus Pharma Ab |
New composition
|
KR100422763B1
(ko)
*
|
2002-01-17 |
2004-03-12 |
주식회사 태평양 |
경피흡수 촉진 능력이 우수한 식물성 나노입자의 제조 및이를 함유하는 화장료 및 의약용 외용제 조성물
|
JP2003342196A
(ja)
*
|
2002-05-31 |
2003-12-03 |
Mukku:Kk |
静脈注射用組成物、その製造法およびその製剤
|
ITMI20022323A1
(it)
*
|
2002-10-31 |
2004-05-01 |
Maria Rosa Gasco |
Composizioni farmaceutiche atte al trattamento di malattie oftalmiche.
|
KR100507771B1
(ko)
*
|
2002-11-08 |
2005-08-17 |
한미약품 주식회사 |
난용성 감기약 활성 성분의 경구투여용 조성물 및 그의제조 방법
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
KR20040084240A
(ko)
*
|
2003-03-27 |
2004-10-06 |
(주) 코스메디 |
고형지질나노입자, 이를 함유하는 활성성분 전달용약학조성물 및 이의 제조방법
|
US7438903B2
(en)
*
|
2003-06-06 |
2008-10-21 |
Nbty, Inc. |
Methods and compositions that enhance bioavailability of coenzyme-Q10
|
WO2005016386A1
(en)
*
|
2003-08-19 |
2005-02-24 |
Meditech Research Limited |
Improved therapeutic protocols
|
JP2007522079A
(ja)
*
|
2003-10-31 |
2007-08-09 |
エラン ファーマ インターナショナル リミテッド |
ニメスリド組成物
|
US20080249076A1
(en)
*
|
2003-12-03 |
2008-10-09 |
Lifecycle Pharma A/S |
Pharmaceutical Compositions Comprising Danazol
|
US7803366B2
(en)
|
2004-05-07 |
2010-09-28 |
Nbty, Inc. |
Methods and compositions that enhance bioavailability of coenzyme-Q10
|
EP1674077A1
(en)
*
|
2004-12-27 |
2006-06-28 |
Université de Liège |
Mucoadhesive pharmaceutical compositions comprising chemoattractants
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
US8252326B2
(en)
|
2005-06-01 |
2012-08-28 |
Catalent Australia Pty Ltd. |
Self-microemulsifying dosage forms of low solubility active ingredients such as co-enzyme Q10
|
CA2651855C
(en)
|
2006-05-30 |
2011-08-02 |
Intarcia Therapeutics, Inc. |
Two-piece, internal-channel osmotic delivery system flow modulator
|
CA2663558C
(en)
*
|
2006-09-26 |
2013-05-28 |
Samyang Corporation |
Submicron nanoparticle of poorly water soluble camptothecin derivatives and process for preparation thereof
|
CA2683610C
(en)
|
2007-04-23 |
2013-01-08 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
CA2689978A1
(en)
|
2007-06-08 |
2008-12-18 |
Addrenex Pharmaceuticals, Inc. |
Extended release formulation and method of treating adrenergic dysregulation
|
WO2009102467A2
(en)
|
2008-02-13 |
2009-08-20 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
FR2943545B1
(fr)
*
|
2009-03-31 |
2011-06-03 |
Univ Claude Bernard Lyon |
Nanoparticules lipidiques solides encapsulant du minoxidil et suspension aqueuse les contenant.
|
EP2462246B1
(en)
|
2009-09-28 |
2017-09-06 |
Intarcia Therapeutics, Inc |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
FR2958150B1
(fr)
|
2010-04-01 |
2012-06-15 |
Univ Claude Bernard Lyon |
Elements orthodontiques elastiques aptes a liberer de la chlorhexidine faiblement soluble dans la salive
|
CN102247320B
(zh)
*
|
2010-05-21 |
2013-03-13 |
天津药物研究院 |
一种依托泊苷长循环乳剂及其制备方法
|
BRPI1002601E2
(pt)
*
|
2010-06-01 |
2020-06-30 |
Embrapa Pesquisa Agropecuaria |
composição nanoestruturada de uso veterinário para administração de fármacos
|
CN101912363A
(zh)
*
|
2010-07-29 |
2010-12-15 |
蔡海德 |
溶解超滤-喷雾干燥-分子分散包衣-水化制粒-冷冻干燥生产脂质体组合药物
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
US10154964B2
(en)
|
2011-09-07 |
2018-12-18 |
Cosmo Technologies Limited |
Controlled release and taste masking oral pharmaceutical composition
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
PT2782584T
(pt)
|
2011-11-23 |
2021-09-02 |
Therapeuticsmd Inc |
Preparações e terapias de substituição para hormonoterapias naturais combinadas
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
FR2995222B1
(fr)
*
|
2012-09-11 |
2016-05-20 |
Creathes |
Procede alternatif de microencapsulation de principe actif
|
US9352047B2
(en)
*
|
2012-11-14 |
2016-05-31 |
Abon Pharmaceuticals, Llc |
Oral transmucosal drug delivery system
|
CN102988285B
(zh)
*
|
2012-12-13 |
2014-02-19 |
哈药集团技术中心 |
一种多西他赛注射液组合物及其制备方法
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
JP2016522251A
(ja)
|
2013-06-20 |
2016-07-28 |
グレンマーク ファーマシューティカルズ, エセ.アー. |
Trpa1アンタゴニストを含むナノ粒子製剤
|
EP2821077A1
(en)
*
|
2013-07-04 |
2015-01-07 |
Praxis Biopharma Research Institute |
Lipid nanoparticles for wound healing
|
MX2016014281A
(es)
|
2014-05-22 |
2017-02-22 |
Therapeuticsmd Inc |
Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
|
WO2015191282A1
(en)
|
2014-06-11 |
2015-12-17 |
Mallinckrodt Llc |
Spray dried compositions having different dissolution profiles and processes for their preparation
|
JP2017523138A
(ja)
|
2014-07-29 |
2017-08-17 |
セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. |
経皮クリーム
|
WO2016016861A1
(en)
*
|
2014-08-01 |
2016-02-04 |
Glenmark Pharmaceuticals S.A. |
Nanoparticulate formulation comprising a mpges-1 inhibitor
|
US10987308B2
(en)
|
2014-09-03 |
2021-04-27 |
Genesegues, Inc. |
Therapeutic nanoparticles and related compositions, methods and systems
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
US10925639B2
(en)
|
2015-06-03 |
2021-02-23 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
WO2017173044A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd Inc. |
Steroid hormone compositions in medium chain oils
|
EP3435977A4
(en)
|
2016-04-01 |
2019-10-16 |
Therapeuticsmd, Inc. |
PHARMACEUTICAL COMPOSITION OF STEROID HORMONE
|
AU2017268161B2
(en)
|
2016-05-16 |
2020-03-12 |
Intarcia Therapeutics, Inc. |
Glucagon-receptor selective polypeptides and methods of use thereof
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
WO2018129058A1
(en)
|
2017-01-03 |
2018-07-12 |
Intarcia Therapeutics, Inc. |
Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
|
EP3999043A4
(en)
*
|
2019-07-19 |
2023-06-21 |
SPI Pharma, INC. |
PREPARATION OF LIPOPHILIC ACTIVE INGREDIENTS
|